Use of combination measles, mumps, rubella, and varicella vaccine recommendations of the advisory committee on immunization practices (ACIP)

Morbidity and Mortality Weekly Report

Volumn 59, Issue RR-3, 2010, Pages 1-12

  Marin, Mona ^a   Broder, Karen R ^b,c   Temte, Jonathan L ^d   Snider, Dixie E ^c   Seward, Jane F ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c University of Wisconsin ^*

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; MEASLES MUMPS RUBELLA VACCINE; MEASLES, MUMPS, RUBELLA, VARICELLA VACCINE; VACCINE;

ARTICLE; CHICKENPOX; CHILD; DRUG CONTRAINDICATION; FEBRILE CONVULSION; HUMAN; IMMUNIZATION; IMMUNOLOGY; INFANT; MEASLES; MUMPS; PRACTICE GUIDELINE; PRESCHOOL CHILD; RUBELLA; UNITED STATES;

CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNIZATION SCHEDULE; INFANT; MEASLES; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS; RUBELLA; SEIZURES, FEBRILE; UNITED STATES; VACCINES, COMBINED;

EID: 77952308759     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. CDC. Measles, mumps, and rubella-vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1998;47(No. RR-8).
2. CDC. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2007;56 (No. RR-4).
3. CDC. Licensure of a combined live attenuated measles, mumps, rubella and varicella vaccine. MMWR 2005;54:1212-4.
4. CDC. Supply of vaccines containing varicella-zoster virus. MMWR 2007;56:146-7.
5. CDC. Update on supply of vaccines containing varicella-zoster virus. MMWR 2007;56:453.
6. Merck & Co., Inc. ProQuad (measles, mumps, rubella, and varicella [Oka/Merck] virus vaccine live) [package insert]. Whitehouse Station, NJ: Merck & Co, Inc; 2009.
7. CDC. Update: recommendations from the Advisory Committee on Immunization Practices (ACIP) regarding administration of combination MMRV vaccine. MMWR 2008;57:258-60.
8. Barlow WE, Davis RL, Glasser JW, et al. The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl J Med 2001;345:656-61.
9. Strebel PM, Dayan GH, Halsey NA. Measles vaccine. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines. 5th ed. Philadelphia: WB Saunders Company; 2008:2004.
10. Vestergaard M, Hviid A, Madsen KM, et al. MMR vaccination and febrile seizures: evaluation of susceptible subgroups and long-term prognosis. JAMA 2004;292:351-7.
11. Jacobsen SJ, Ackerson BK, Sy LS, et al. Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting. Vaccine 2009;27:4656-61.
12. Shinefield H, Black S, Digilio L, et al. Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children. Pediatr Infect Dis J 2005;24:665-9.
13. Kuter BJ, Brown ML, Hartzel J, et al. Safety and immunogenicity of a combination measles, mumps, rubella and varicella vaccine (ProQuad). Hum Vaccin 2006;2:205-14.
14. Seizures in Childhood. In: Kliegman RM, Berhman RE, Jenson HB, Stanton BF, eds. Nelson textbook of pediatrics. 18th ed. Philadelphia, PA: Saunders; 2007:2457-75.
15. Bonhoeffer J, Menkes J, Gold MS, et al. Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. Vaccine 2004;22:557-62.
16. Lieu TA, Kulldorff M, Davis RL, et al. Real-time vaccine safety surveillance for the early detection of adverse events. Med Care 2007;45:S89-S95.
17. Klein N for the Vaccine Safety Datalink MMRV team. Evaluation of MMRV and febrile seizures: updated VSD analyses with chart review results. Presented at the meeting of the Advisory Committee on Immunization Practices; June 25, 2009; Atlanta, Georgia. Available at http://www.cdc.gov/vaccines/recs/ACIP/slides-jun09.htm. Accessed April 25, 2010.
18. Klein NP, Fireman B, Yih WK, et al. Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics 2010. In press.
19. Reisinger KS, Brown ML, Xu J, et al. A combination measles, mumps, rubella, and varicella vaccine (ProQuad) given to 4- to 6-year-old healthy children vaccinated previously with M-M-RII and Varivax. Pediatrics 2006;117:265-72.
20. Broder K, Marin M, Temte J on behalf of the ACIP MMRV Vaccine Safety Working Group. Synthesis of evidence for febrile seizure risk after MMRV vaccination. Presented at the meeting of the Advisory Committee on Immunization Practices; June 25, 2009; Atlanta, Georgia. Available at http://www.cdc.gov/vaccines/recs/ACIP/slides-jun09.htm. Accessed April 25, 2010.
21. Black S, Shinefield H, Ray P, et al. Postmarketing evaluation of the safety and effectiveness of varicella vaccine. Pediatr Infect Dis J 1999;18:1041-6.
22. Sillanpaa M, Camfield P, Camfield C, et al. Incidence of febrile seizures in Finland: prospective population-based study. Pediatr Neurol 2008;38:391-4.
23. Baulac S, Gourfinkel-An I, Nabbout R, et al. Fever, genes, and epilepsy. Lancet Neurol 2004;3:421-30.
24. Balslev T. Parental reactions to a child's first febrile convulsion: a follow-up investigation. Acta Paediatr Scand 1991;80:466-9.
25. Baumer JH, David TJ, Valentine SJ, et al. Many parents think their child is dying when having a first febrile convulsion. Dev Med Child Neurol 1981;23:462-4.
26. Jones T, Jacobsen SJ. Childhood febrile seizures: overview and implications. Int J Med Sci 2007;4:110-4.
27. Parmar RC, Sahu DR, Bavdekar SB. Knowledge, attitude and practices of parents of children with febrile convulsion. J Postgrad Med 2001;47:19-23.
28. Janssen AP. Pediatricians' and mothers' perceptions of MMRV vaccine. Presented at the meeting of the Advisory Committee on Immunization Practices; June 25, 2009; Atlanta, Georgia. Available at http://www.cdc.gov/vaccines/recs/ACIP/downloads/mtg-slides-jun09/13-2-mmrv.pdf. Accessed April 25, 2010.
29. Suh CA, Huang WT, Crane LA, et al. Febrile seizures and MMRV vaccine: a national survey of physicians [late-breaker presentation]. Meeting of the Pediatric Academic Societies; May 2-5, 2009; Baltimore, Maryland.
30. Katz SL, Hinman AR. Summary and conclusions: measles elimination meeting, 16-17 March 2000. J Infect Dis 2004;189(Suppl 1):S43-S47.
31. Reef SE, Cochi SL. The evidence for the elimination of rubella and congenital rubella syndrome in the United States: a public health achievement. Clin Infect Dis 2006;43(Suppl 3):S123-S125.
32. Barskey AE, Glasser JW, LeBaron CW. Mumps resurgences in the United States: A historical perspective on unexpected elements. Vaccine 2009;27:6186-95.
33. CDC. Update: mumps outbreak--New York and New Jersey, June 2009-January 2010. MMWR 2010;59:125-9.
34. Guris D, Jumaan AO, Mascola L, et al. Changing varicella epidemiology in active surveillance sites--United States, 1995-2005. J Infect Dis 2008;197(Suppl 2):S71-S75.
35. Update: measles--United States, January-July 2008. MMWR 2008;57:893-6.
36. Food and Drug Administration. MMRV clinical review. Available at http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm123800.pdf. Accessed April 25, 2010.
37. CDC. National, state, and local area vaccination coverage among children aged 19-35 months, United States, 2008. MMWR 2009;58:921-6.
38. Kolasa MS, Klemperer-Johnson S, Papania MJ. Progress toward implementation of a second-dose measles immunization requirement for all schoolchildren in the United States. J Infect Dis 2004;189 Suppl 1:S98-S103.
39. Happe LE, Lunacsek OE, Kruzikas DT, et al. Impact of a pentavalent combination vaccine on immunization timeliness in a state Medicaid population. Pediatr Infect Dis J 2009;28:98-101.
40. Marshall GS, Happe LE, Lunacsek OE, et al. Use of combination vaccines is associated with improved coverage rates. Pediatr Infect Dis J 2007;26:496-500.
41. Davis RL, Coplan P, Mell L, et al. Impact of the introduction of a combined Haemophilus B conjugate vaccine and hepatitis B recombinant vaccine on vaccine coverage rats in a large West Coast health maintenance organization. Pediatr Infect Dis J 2003;22:657-8.
42. Meyerhoff A, Jacobs RJ, Greenberg DP, et al. Clinician satisfaction with vaccination visits and the role of multiple injections, results from the COVISE Study (Combination Vaccines Impact on Satisfaction and Epidemiology). Clin Pediatr (Phila) 2004;43:87-93.
43. Woodin KA, Rodewald LE, Humiston SG, et al. Physician and parent opinions. Are children becoming pincushions from immunizations? Arch Pediatr Adolesc Med 1995;149:845-9.
44. Lieu TA, Black SB, Ray GT, et al. The hidden costs of infant vaccination. Vaccine 2000;19:33-41.
45. Kempe, A. Providers' opinions on the use of MMRV vaccine. Presented at the meeting of the Advisory Committee on Immunization Practices; February 26, 2009; Atlanta, Georgia. Available at http://www.cdc.gov/vaccines/recs/ACIP/downloads/mtg-slides-feb09/16-3-mmrv.pdf. Accessed April 25, 2010.
46. Perry RT, Halsey NA. The clinical significance of measles: a review. J Infect Dis 2004;189(Suppl 1):S4-S16.
47. CDC. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2006;55(No. RR-15).
48. CDC, Advisory Committee on Immunization Practices. Provisional recommendations for the use of combination vaccines. Atlanta, GA: US Department of Health and Human Services, CDC; 2009. Available at http://www.cdc.gov/vaccines/recs/provisional/downloads/combo-vax-Aug2009-508.pdf. Accessed April 25, 2010.
49. Berg AT, Shinnar S, Shapiro ED, et al. Risk factors for a first febrile seizure: a matched case-control study. Epilepsia 1995;36:334-41.
50. American Academy of Pediatrics. Febrile seizures: clinical practice guideline for the long-term management of the child with simple febrile seizures. Pediatrics 2008;121:1281-6.